$LPNT (LifePoint Health, Inc.)

$LPNT {{ '2016-01-04T14:21:04+0000' | timeago}} • Announcement

Duke LifePoint Healthcare, a joint venture of Duke University Health System and $LPNT, said it acquired Central Carolina Hospital, a 137-bed hospital in Sanford, and Frye Regional Medical Center, a 355-bed hospital in Hickory, previously owned by $THC. This acquisition included 19 regional physician practices. Terms of the sale are not disclosed.

$HCA {{ '2017-07-21T20:39:36+0000' | timeago}} • Announcement

$HCA has agreed to acquire Highlands Regional Medical Center in Sebring, Florida, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close in the fall of 2017.

$MCK {{ '2017-07-21T16:07:44+0000' | timeago}} • Announcement

Biologics, a unit of healthcare technology firm $MCK, said it will join the limited distribution network of $PBYI to promote the latter’s kinase inhibitor Nerlynx. The formulation is indicated for treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer.

$MRK {{ '2017-07-21T15:21:07+0000' | timeago}} • Announcement

President Donald Trump announced that pharma giants $MRK and $PFE are collaborating with Gorilla Glass manufacturer Corning ($GLW) for manufacturing a new glass (Valor Glass), which is superior and reliable for the delivery of injectable drugs. Corning is planning to initially invest $500MM creating 1,000 jobs at 3 facilities in US.

$MRK {{ '2017-07-20T14:29:27+0000' | timeago}} • Announcement

$MRK announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for its 100 units/mL insulin glargine injection, a follow-on biologic basal insulin in a pre-filled dosing device.

$HLS {{ '2017-07-20T13:56:35+0000' | timeago}} • Announcement

The BoD of $HLS declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on Oct. 16, 2017, to stockholders of record on Oct. 2, 2017.

$UHS {{ '2017-07-19T22:35:19+0000' | timeago}} • Announcement

$UHS BoD approved a cash dividend of $0.10 per share on Sept. 15, 2017 to shareholders of record as of Sept. 1, 2017.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$VRX {{ '2017-07-17T14:04:54+0000' | timeago}} • Announcement

$VRX has entered into an agreement to sell its Obagi Medical Products business for $190MM in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. The transaction is expected to close in second half of 2017. $VRX intends to use the proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility.

$MGLN {{ '2017-07-13T12:33:15+0000' | timeago}} • Announcement

Health care company $MGLN has entered into a definitive agreement to acquire Senior Whole Health (SWH) for $400MM cash, inclusive of $10MM contingent payment. $MGLN anticipates paying the purchase price from the proceeds of new debt offerings. The company expects to close the transaction by end of the 1Q18.

$VRTX {{ '2017-07-13T12:31:35+0000' | timeago}} • Announcement

$VRTX announced that the Italian Medicines Agency has agreed to reimburse ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older who have two copies of the F508del mutation. Effective immediately, hundreds of eligible patients in Italy will have access to this medicine.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$CYH {{ '2017-07-12T11:46:04+0000' | timeago}} • Announcement

Hospital operator $CYH said its subsidiaries have signed a definitive agreement to sell Weatherford Regional Medical Center in Texas, and its associated assets, to the subsidiaries of $HCA. The transaction is expected to close later this year. The company is planning to divest a total of 30 hospitals.

$HCA {{ '2017-07-11T22:05:57+0000' | timeago}} • Announcement

$HCA announced an agreement to acquire Weatherford Regional Medical Center outside Fort Worth, Texas, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close by the fall of 2017.

$SEM {{ '2017-07-11T15:58:57+0000' | timeago}} • Announcement

$SEM subsidiary Select Medical Corp. has opened a new rehabilitation hospital, in a joint venture partnership with SSM Health.  SSM Health Rehabilitation Hospital - Lake Saint Louis, which offers rehabilitation care for acute medical conditions, is the first such facility having a brain injury unit.

$HLS {{ '2017-07-11T10:50:33+0000' | timeago}} • Announcement

$HLS expects the total rebranding investment to be about $25-30MM, to be incurred between 2017 and 2019. About $7-10MM is expected to be incurred in 2017, of which $6-8MM will be operating expenses and $1-2MM will be capital expenditures. Only $1MM of this investment is included in 2017 forecast which will be updated in 2Q17 results.

$HLS {{ '2017-07-11T10:46:49+0000' | timeago}} • Announcement

$HLS said it will change its name to Encompass Health Corp., effective Jan. 2, 2018. The corporate name change will be accompanied by a NYSE ticker symbol change, from $HLS to "EHC". Beginning in 1Q18, both business segments will begin transitioning to the Encompass Health name.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$VRX {{ '2017-07-10T13:27:06+0000' | timeago}} • Announcement

$VRX pays down $811MM of senior secured term loans using the net proceeds of the sale of Dendreon Pharmaceuticals LLC. The company has now reduced its debt by more than $4.3Bil since the end of 1Q16. $VRX still expects to pay down $5Bil in debt from divestiture proceeds and free cash flow within 18 months of August 2016.

$ENSG {{ '2017-07-10T13:23:49+0000' | timeago}} • Announcement

$ENSG acquired the real estate and operations of two continuing care retirement communities in Colorado. The acquisition was effective July 1, 2017. $ENSG is actively seeking additional opportunities to buy real estate or to lease both well-performing and struggling skilled nursing, assisted living and other healthcare related businesses.

$MRK {{ '2017-07-06T12:50:08+0000' | timeago}} • Announcement

Pharma company $MRK will present its HIV portfolio and pipeline at the 9th IAS Conference on HIV Science. The presentations include late-breaker abstracts from two phase-3 pivotal clinical trials and a phase-1 study of MK-8591, Merck’s investigational nucleoside reverse transcriptase translocation inhibitor in adult patients with HIV-1 infection.

Recent Transcripts

SRPT (Sarepta Therapeutics, Inc.)
Wednesday, July 19 2017 - 8:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, May 9 2017 - 12:00pm
FVE (Five Star Quality Care Inc.)
Friday, May 5 2017 - 2:00pm
SEM (Select Medical Holdings Corporation)
Friday, May 5 2017 - 1:00pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
FMS (Fresenius Medical Care AG & Co. KGAA)
Wednesday, May 3 2017 - 1:30pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
CYH (Community Health Systems, Inc.)
Tuesday, May 2 2017 - 4:00pm
HCA (HCA Holdings, Inc.)
Tuesday, May 2 2017 - 3:00pm
THC (Tenet Healthcare Corp.)
Tuesday, May 2 2017 - 2:00pm
MRK (Merck & Co. Inc.)
Tuesday, May 2 2017 - 12:00pm
ENSG (The Ensign Group, Inc.)
Monday, May 1 2017 - 5:00pm
LPNT (LifePoint Health, Inc.)
Friday, April 28 2017 - 2:00pm
HLS (HEALTHSOUTH Corp.)
Friday, April 28 2017 - 1:00pm
VRTX (Vertex Pharmaceuticals Incorporated)
Thursday, April 27 2017 - 8:30pm
SRPT (Sarepta Therapeutics, Inc.)
Thursday, April 27 2017 - 8:30pm

AlphaGraphics you may like